πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

325 results for β€œDisc” Clear

  1. The detection of tumor-associated fibrosis in colorectal peritoneal metastases by FAPI-PET (TROMPET)

    Disc Medicine

    Metastatic colorectal cancer

    phase 1 other active

    1 trial
  2. Treatment of cancer with Immune Checkpoint Inhibition therapy boosted by High Intensity Focused Ultrasound Histotripsy (the iFOCUS study)

    Disc Medicine

    Metastatic or unresectable solid malignancies. Standard of care treatment options must not be available or not be considered feasible. Patients must have a primary tumor or metastasis that is suitable for HIFU-HT treatment.

    phase 1 other active

    1 trial
  3. 18F-Canagliflozin, Invokana 300 mg film-coated tablets

    Disc Medicine

    Chronic Kidney disease

    approved small molecule active

    1 trial
  4. ACETYLSALICYLIC ACID , CLOPIDOGREL , RIVAROXABAN

    Disc Medicine

    Peripheral Arterial Disease

    approved small molecule active

    1 trial
  5. ADALIMUMAB , INFLIXIMAB

    Disc Medicine

    Crohn's disease Ulcerative colitis

    approved small molecule active

    1 trial
  6. ALITRETINOIN, CICLOSPORIN, ALITRETINOIN, CICLOSPORIN

    Disc Medicine

    Hand eczema

    approved small molecule active

    1 trial
  7. AMINOHIPPURIC ACID , IOTALAMATE MEGLUMINE, Adrenaline CF 1 mg/ml, oplossing voor injectie, OMNIPAQUE 300 mg I/ml, Tavegyl 1 mg/ml, oplossing voor injectie, SODIUM IOTALAMATE (125I)

    Disc Medicine

    Chronic Kidney Disease Kidney Failure

    approved small molecule active

    1 trial
  8. ARIPIPRAZOLE , RISPERIDONE

    Disc Medicine

    Autism spectrum disorder

    approved small molecule active

    1 trial
  9. ATORVASTATIN, PLACEBO

    Disc Medicine

    Atherosclerosis

    approved small molecule active

    1 trial
  10. Acetylsalicylzuur Aurobindo cardio 80 mg, tabletten.

    Disc Medicine

    ST elevation myocardial infarction (STEMI)

    approved small molecule active

    1 trial
  11. Alecensa 150 mg hard capsules

    Disc Medicine

    ALK positive non-small cell lung cancer

    approved small molecule active

    1 trial
  12. Amoxicillin 500 mg film-coated tablets, Placebo amoxicillin capsules 500mg

    Disc Medicine

    non-specific low back pain

    approved small molecule active

    1 trial
  13. Atropine 1.0% eye drops solution

    Disc Medicine

    Myopia

    approved small molecule active

    1 trial
  14. Avastin 25 mg/ml concentrate for solution for infusion., KEYTRUDA 25 mg/mL concentrate for solution for infusion.

    Disc Medicine

    Metastatic cervical cancer

    approved small molecule active

    1 trial
  15. BECLOMETASONE , FLUTICASONE , BUDESONIDE , SALBUTAMOL

    Disc Medicine

    Episodic expiratory wheezing

    approved small molecule active

    1 trial
  16. Bavencio 20 mg/mL concentrate for solution for infusion

    Disc Medicine

    urothelial cancer, Bladder cancer, muscle invasive bladder cancer

    approved small molecule active

    1 trial
  17. Brilique 90 mg film-coated tablets, Clopidogrel Medreg 75 mg filmom obalenΓ© tablety

    Disc Medicine

    Patients with coronary artery disease and an indication for PCI

    approved small molecule active

    1 trial
  18. CAPVAXIVE solution for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (21-valent), Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)

    Disc Medicine

    Asplenia

    approved small molecule active

    1 trial
  19. CELLULOSE, MICROCRYSTALLINE, Diltiazem HCl Auro retard 120 mg, tabletten met gereguleerde afgifte

    Disc Medicine

    Angina

    approved small molecule active

    1 trial
  20. CELLULOSE, MICROCRYSTALLINE, YOCORAL 5 mg tabletten, Hydrocortison Teva 10 mg, filmomhulde tabletten

    Disc Medicine

    Mimic an acute stress response in humans.

    approved small molecule active

    1 trial
  21. COBICISTAT , OLAPARIB

    Disc Medicine

    Cancer

    approved small molecule active

    1 trial
  22. COMBINATIONS

    Disc Medicine

    muscle protein turnover hemodialysis

    approved small molecule active

    1 trial
  23. Capsules with microcrystalline cellulose, Colchicine Teva 0,5 mg, tabletten

    Disc Medicine

    Type 1 Diabetes

    approved small molecule active

    1 trial
  24. Ceftriaxon Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie, Ceftazidim Fresenius Kabi 500 mg poeder voor oplossing voor injectie, Amoxicilline/Clavulaanzuur Sandoz 2000 mg/200 mg i.v., poeder voor oplossing voor intraveneuze infusie, Cefuroxim Hikma 1500 mg poeder voor oplossing voor injectie of infusie, Meropenem CF 1000 mg, poeder voor oplossing voor injectie of infusie, Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie, Piperacilline/Tazobactam Fresenius Kabi 2

    Disc Medicine

    Sepsis

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources